Insider · CIK 0001401267

Huh Hoyoung

Reports to the SEC for 9 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001401267

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+70K sh	—	—	70,000
2025-12-16	AKTXAkari Therapeutics Plc · Warrants to purchase American Depositary Shares ("ADRs")P Purchase	Director, 10% Owner	PPurchase	+619K sh	—	—	618,658
2025-12-16	AKTXAkari Therapeutics Plc · Pre-Funded Warrants to purchase ADRsP Purchase	Director, 10% Owner	PPurchase	+3.09M sh	$0.40	+$1.25M	3,093,293
2025-12-16	AKTXAkari Therapeutics Plc · Warrants to purchase ADRsP Purchase	Director, 10% Owner	PPurchase	+3.09M sh	—	—	3,093,293
2025-12-16	AKTXAkari Therapeutics Plc · Pre-Funded Warrants to purchase ADRsP Purchase	Director, 10% Owner	PPurchase	+619K sh	$0.40	+$250K	618,658
2025-06-05	PLRXPLIANT THERAPEUTICS, INC. · Common Stock (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-03-20	AKTXAkari Therapeutics Plc · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+225K sh	—	—	225,000
2025-03-20	AKTXAkari Therapeutics Plc · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+175K sh	—	—	175,000
2025-03-06	AKTXAkari Therapeutics PlcA Award	Director, 10% Owner	AAward	+893K sh	$1.12	+$1M	4,695,854
2025-03-06	AKTXAkari Therapeutics Plc · Series B Warrants (Right to Buy)A Award	Director, 10% Owner	AAward	+893K sh	$1.12	+$1M	892,857
2025-03-06	AKTXAkari Therapeutics Plc · Series A Warrants (Right to Buy)A Award	Director, 10% Owner	AAward	+893K sh	$1.12	+$1M	892,857
2024-11-14	Peak Bio, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−373K sh	—	—	0
2024-11-14	Peak Bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−1.2M sh	—	—	0
2024-11-14	Peak Bio, Inc.Warrant (Right to Purchase)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−176K sh	—	—	0
2024-11-14	Peak Bio, Inc.C Conversion	Director, 10% Owner	CConversion	+4.57M sh	—	—	4,574,661
2024-11-14	Peak Bio, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−4.57M sh	—	—	0
2024-11-14	Peak Bio, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−8.38M sh	—	—	0
2024-11-14	Peak Bio, Inc.Convertible NotesC Conversion	Director, 10% Owner	CConversion	—	—	—	0
2024-06-13	PLRXPLIANT THERAPEUTICS, INC. · Common Stock (Right to Buy)A Award	Director	AAward	+26.8K sh	—	—	26,764
2023-09-21	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	+45K sh	—	—	8,382,742
2023-09-20	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	+30K sh	—	—	8,337,742
2023-09-19	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	+50K sh	—	—	8,307,742
2023-09-15	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	+25K sh	—	—	8,257,742
2023-09-14	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	+20K sh	—	—	8,232,742
2023-09-13	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	+30K sh	—	—	8,212,742
2023-09-12	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	+17K sh	—	—	8,182,742
2023-09-11	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	+30K sh	—	—	8,165,742
2023-08-31	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	+13K sh	$0.27	+$3,445	8,228,992
2023-08-31	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	0 sh	—	—	8,135,742
2023-08-30	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	+56.1K sh	$0.26	+$14.3K	8,215,992
2023-08-30	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	0 sh	—	—	8,135,742
2023-08-30	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	0 sh	—	—	8,135,742
2023-08-30	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	+11.4K sh	$0.27	+$3,021	8,159,892
2023-08-30	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	0 sh	—	—	8,135,742
2023-08-30	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	+2,500 sh	$0.26	+$650	8,144,742
2023-08-30	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	+1,000 sh	$0.25	+$253	8,142,242
2023-08-30	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	0 sh	—	—	8,135,742
2023-08-30	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	+3,750 sh	$0.25	+$941.25	8,148,492
2023-08-30	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	0 sh	—	—	8,135,742
2023-08-29	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	0 sh	—	—	8,135,742
2023-08-29	Peak Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	+5,500 sh	$0.25	+$1,375	8,141,242
2023-08-14	Peak Bio, Inc.Warrant (Right to Purchase)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−583K sh	—	—	176,292
2023-08-14	Peak Bio, Inc.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+583K sh	$0.60	+$350K	8,135,742
2023-07-20	Peak Bio, Inc.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+458K sh	$0.60	+$275K	7,552,409
2023-07-20	Peak Bio, Inc.Warrant (Right to Purchase)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−458K sh	—	—	759,625
2023-06-23	Peak Bio, Inc.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+667K sh	$0.60	+$400K	7,094,076
2023-06-23	Peak Bio, Inc.Warrant (Right to Purchase)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−667K sh	—	—	1,217,958
2023-06-07	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,000
2023-04-28	Peak Bio, Inc.Convertible NotesA Award	Director, 10% Owner	AAward	—	$1130775.00	—	—
2023-04-28	Peak Bio, Inc.Warrant (Right to Purchase)A Award	Director, 10% Owner	AAward	+1.88M sh	—	—	1,884,625

Recent filings

Accepted (ET)
Jun 124
Huh Hoyoung0001746473-26-000100
SEC(opens sec.gov)
Dec 184
Huh Hoyoung0001493152-25-028420
SEC(opens sec.gov)
Jun 94
Huh Hoyoung0001746473-25-000125
SEC(opens sec.gov)
Mar 244
Huh Hoyoung0000950170-25-043936
SEC(opens sec.gov)
Mar 104
Huh Hoyoung0000950170-25-036488
SEC(opens sec.gov)
Nov 184
Huh Hoyoung0000950170-24-128149
SEC(opens sec.gov)
Jun 174
Huh Hoyoung0001746473-24-000106
SEC(opens sec.gov)
Sep 254
Huh Hoyoung0000950170-23-049688
SEC(opens sec.gov)

Companies

Address

C/O PLIANT THERAPEUTICS, INC. 331 OYSTER POINT BOULEVARD

SOUTH SAN FRANCISCO, CA, 94080